Potential crosstalk between Naïve CD4+ T cells and SPP1+ Macrophages is associated with clinical outcome and therapeutic response in hepatocellular carcinoma
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.113231 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Libin Dong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou 310058, Zhejiang, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, CD4-Positive T-Lymphocytes, Macrophages. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Zhejiang Province Natural Science Foundation, National Key Research and Development Program of China.
Abstract (Originalsprache)
BACKGROUND: The highly heterogeneity of the tumor microenvironment (TME) in hepatocellular carcinoma (HCC) results in diverse clinical outcomes and therapeutic responses. This study aimed to investigate potential intercellular crosstalk and its impact on clinical outcomes and therapeutic responses. METHODS: Single-cell RNA sequencing (scRNA-seq), spatial transcriptomics (ST) and bulk RNA sequencing (RNA-seq) datasets were integrated to comprehensively analyze the intercellular interactions within the TME. Multiplex immunohistochemistry was conducted to validate the intercellular interactions. A machine learning-based integrative procedure was used in bulk RNA-seq datasets to generate a risk model to predict prognosis and therapeutic responses. RESULTS: Survival analyses based on the bulk RNA-seq datasets revealed the negative impact of the naïve Cluster of Differentiation 4+ (CD4) T cells and Secreted Phosphoprotein 1+ (SPP1) macrophages on prognosis. Furthermore, their intricate intercellular crosstalk and spatial colocalization were also observed by scRNA-seq and ST analyses. Based on this crosstalk, a machine learning model, termed the naïve CD4+ T cell and SPP1+ macrophage prognostic score (TMPS), was established in the bulk-RNA seq datasets for prognostic prediction. The TMPS achieved C-index values of 0.785, 0.715, 0.692 and 0.857, respectively, across 4 independent cohorts. A low TMPS was associated with a significantly increased survival rates, improved response to immunotherapy and reduced infiltration of immunosuppressive cells, such as. regulatory T cells. Finally, 8 potential sensitive drugs and 6 potential targets were predicted for patients based on their TMPS. CONCLUSION: The crosstalk between naïve CD4+ T cells and SPP1+ macrophages play a crucial role in the TME. TMPS can reflect this crosstalk and serve as a valuable tool for prognostic stratification and guiding clinical decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou 310058, Zhejiang, China.
- Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang, China.
- Institute of Quantitative Biology, Shanghai Institute for Advanced Study, College of Life Sciences, Zhejiang University, Hangzhou 310027, Zhejiang, China.
- Department of Cell Biology, Zhejiang University School of Medicine, Hangzhou 310058, Zhejiang, China.
- Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou 310058, Zhejiang, China; School of Clinical Medicine, Hangzhou Medical College, Hangzhou 310059, Zhejiang, China. Electronic address:…
- School of Clinical Medicine, Hangzhou Medical College, Hangzhou 310059, Zhejiang, China. Electronic address: kaiw3@zju.edu.cn.
Förderung
- National Natural Science Foundation of China
- Zhejiang Province Natural Science Foundation
- National Key Research and Development Program of China
- National Key Research and Development Program of China Stem Cell and Translational Research
- Zhejiang Province Department of Education
Zitieren
APA
Dong, L., Qiu, X., Li, Z., Ge, W., Tang, X., Zhou, R., Chen, W., Xu, X., & Wang, K. (2024). Potential crosstalk between Naïve CD4+ T cells and SPP1+ Macrophages is associated with clinical outcome and therapeutic response in hepatocellular carcinoma. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113231
Vancouver
Dong L, Qiu X, Li Z, Ge W, Tang X, Zhou R, et al. Potential crosstalk between Naïve CD4+ T cells and SPP1+ Macrophages is associated with clinical outcome and therapeutic response in hepatocellular carcinoma. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113231
BibTeX
@article{Dong2024,
author = {Dong, Libin and Qiu, Xun and Li, Zekuan and Ge, Wenwen and Tang, Xiao and Zhou, Ruhong and Chen, Wei and Xu, Xiao and Wang, Kai},
title = {Potential crosstalk between Naïve CD4+ T cells and SPP1+ Macrophages is associated with clinical outcome and therapeutic response in hepatocellular carcinoma},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.113231}
}
EUVIMED